The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 5 , Pages 1146-1152 , May 2010

The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation

Read at the Thirty-fifth Annual Meeting of The Western Thoracic Surgical Association, Banff, Alberta, Canada, June 24–27, 2009.

Received 30 June 2009 ,Revised 15 December 2009 ,Accepted 27 January 2010.

References 

  1. Riley M, Marrouche N. Ablation of atrial fibrillation. Curr Probl Cardiol. 2006;31:361–390
  2. Ad N. Surgical treatment for atrial fibrillation—the Cox-Maze procedure: past, present and future. In:  Sie H,  D'Anocoa G,  Batolozzi F,  Beukema W,  Doty D editor. Manual of surgical treatment of atrial fibrillation. Malden, Mass: Blackwell; 2007;p. 160–164
  3. Cox JL, Scussler RB, D'Agostino HJ, et al. The surgical treatment of atrial fibrillation. III. Development of a definite surgical procedure. J Thorac Cardiovasc Surg. 1991;101:569–583
  4. Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg. 1991;101:584–592
  5. Cox JL, Boineau JP, Schuessler RB, et al. Modifications of the Cox-Maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. J Thorac Cardiovasc Surg. 1995;110:473–483
  6. Cox JL, Jaquiss RD, Schuessler RB, et al. Modifications of the Cox-Maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the Cox-Maze III procedure. J Thorac Cardiovasc Surg. 1995;110:485–495
  7. Damiano RJ, Gaynor SL, Bailey M, et al. The long term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox-Maze procedure. J Thorac Cardiovasc Surg. 2003;126:2016–2021
  8. Prasad SM, Maniar HS, Camillo CJ, et al. The Cox-Maze III procedure for atrial fibrillation: long term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg. 2003;126:1822–1828
  9. A report of the Heart Rhythm Society (HRS) Task Force on Catheter Ablation of Atrial Fibrillation developed in partnership with European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace. 2007;9:330–379
  10. Ware J, Kosinski M, Turner-Bowker D, Gandek B. How to score version 2 of the SF-12 health survey. Lincoln, RI: Quality Metric Inc; 2002;
  11. Ad N, Pirovic EA, Kim YD, et al. Observations on the perioperative management of patients undergoing the Cox-Maze procedure. Semin Thorac Cardiovasc Surg. 2000;12:63–67
  12. Ad N, Barnett S, Lefrak E, et al. Impact of follow up on the success rate of cryoCox-Maze procedure in patients with rheumatic cardiac disease and enlarged atria. J Thorac Cardiovasc Surg. 2006;131:1073–1079
  13. Ad N, Tian YY, Verbalis J, Imahara SD, Cox JL. The effect of the Cox-Maze procedure on the secretion of arginine-vasopressin and aldosterone. J Thorac Cardiovasc Surg. 2003;126:1095–1100
  14. Ad N, Suyderhoud JP, Kim YD, et al. The benefits of prophylactic continuous infusion of furosemide after the Cox-Maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2002;123:232–236
  15. Halonen J, Hakala T, Auvinen T, et al. Intravenous administration of metroprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery. Circulation. 2006;114:I1–I4
  16. Denevich S, Boci K, Reddy P. Cost effectiveness of amiodarone in cardiac surgery. Future Drugs—Expert Review of Pharmacoeconomics and Outcomes Research. 2007;7:19–30
  17. Auer J, Weber T, Berent R, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo controlled trial. Am Heart J. 2004;147:636–643
  18. Ad N, Cox JL, Palazzo T, et al. Stroke prevention as an indication for the Cox-Maze procedure in the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2000;12:56–62
  19. Cox JL, Ad N, Pallazo T. Impact of the Cox-Maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118:833–840
  20. Division for heart disease and stroke prevention—atrial fibrillation fact sheet. Available at: http://apps.nccd.cdc.gov/emailform/print_table.asp. Accessed October 19, 2008.
  21. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Available at: content.onlinejacc.org by. Accessed August 22, 2006.
  22. Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg. 2006;131:1029–1035

PII: S0022-5223(10)00111-X

doi: 10.1016/j.jtcvs.2010.01.034

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 5 , Pages 1146-1152 , May 2010